Harald Reinhart

Harald Reinhart

President, Head of Global Development, Neuroscience, Autoimmune, and Infectious Diseases.atZai Lab· In proxies 2021–2023

Pay in FY2023-38% from the year before · Zai Lab stock -11.0% the same year

Harald Reinhart was paid $4.1M in FY2023 (Dec), down 38%. Zai Lab stock fell 11.0% that year.

Pay$100 in the stock at the end of FY20 → $20
Pay is from the Summary Compensation Table of each Zai Lab proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zai LabPublic company · 5 yr
    • President, Head of Global Development, Neuroscience, Autoimmune, and Infectious Diseases.2021 – Present · 5 yrStock in role -83%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?